Filters close
Released: 31-Oct-2023 2:05 PM EDT
Resiliency and Vulnerability of Global Supply Chains During the Covid-19 Pandemic
George Washington University

New research is diving more closely into the resiliency and vulnerability of global supply chains during the Covid-19 pandemic.

Released: 31-Oct-2023 12:05 PM EDT
COVID vaccination in female, male partners does not increase risk of miscarriage
Boston University School of Public Health

Multiple studies have shown that the COVID-19 vaccines do not lead to infertility or pregnancy complications such as miscarriage, but many people are still wary of adverse effects from the vaccine on pregnancy.

Newswise: Researchers Show SARS-Cov-2 Infection Affects Energy Stores in the Body, Causing Organ Failure
Released: 31-Oct-2023 11:05 AM EDT
Researchers Show SARS-Cov-2 Infection Affects Energy Stores in the Body, Causing Organ Failure
University of North Carolina School of Medicine

An international research team, including Jonathan C. Schisler, PhD, in the UNC School of Medicine, has found how SARS-CoV-2 causes widespread “energy outages” throughout major organs, and how these effects contribute to debilitating long COVID symptoms.

Not for public release

This news release is embargoed until 30-Oct-2023 5:00 PM EDT Released to reporters: 24-Oct-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Oct-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 30-Oct-2023 1:00 PM EDT
Strategies Behind Near-Zero COVID-19 Incidence in NBA “Bubble” Published in ADLM’s The Journal of Applied Laboratory Medicine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

A report published today in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) The Journal of Applied Laboratory Medicine describes the strategies used by the National Basketball Association (NBA) to limit COVID-19 exposure among the individuals who participated in the 2019–2020 season. The success of the NBA’s approach demonstrates that strict adherence to certain protocols can be highly effective in preventing disease outbreaks in a self-contained environment and serves as a model for future pandemic management.

Released: 27-Oct-2023 11:05 AM EDT
Long COVID most prevalent in the most seriously ill
Karolinska Institute

Severe physical symptoms persist for up to two years in people who had a severe COVID-19 infection, highlighting the importance of long-term monitoring.

Released: 26-Oct-2023 10:05 AM EDT
A new era for accurate, rapid COVID-19 testing
Osaka University

Research out of Osaka University unveils a novel technique to detect different coronavirus variants quickly, including fast-spreading strains present in human saliva

Newswise: A new era for accurate, rapid COVID-19 testing
Released: 26-Oct-2023 1:00 AM EDT
A new era for accurate, rapid COVID-19 testing
Hokkaido University

Research from Osaka University demonstrates a nanopore-based technique that can detect different variants of SARS-CoV-2, the virus that causes COVID-19. The method was very effective in detecting the Omicron variant of the virus in the saliva of people with COVID-19.

Released: 25-Oct-2023 12:05 PM EDT
Post-COVID condition is not linked to ongoing infection or active brain damage
University of Gothenburg

Post COVID-19 condition does not appear to be linked to direct viral invasion of the brain or active brain damage. This has been shown by a study at the University of Gothenburg. Searching for abnormal biomarkers among the participants yielded no hits in either blood or cerebrospinal fluid samples

Released: 25-Oct-2023 12:05 PM EDT
People with severe mental illness at 50 per cent higher risk of death following COVID-19 infection
King's College London

New research from King’s College London has found that in the UK people with severe mental illness were at increased risk of death from all causes following COVID-19 infection compared to those without severe mental illness

Released: 25-Oct-2023 11:05 AM EDT
Global platform study presents results to guide care of severely ill patients with COVID-19 using routinely available drugs
University of Pittsburgh

The world’s largest trial of multiple interventions for critically ill adults with COVID-19 has simultaneously released results about two of its treatments, vitamin C and simvastatin

Newswise: Dr. Anthony Fauci to be awarded 2024 Inamori Ethics Prize by Inamori International Center for Ethics and Excellence
24-Oct-2023 12:05 PM EDT
Dr. Anthony Fauci to be awarded 2024 Inamori Ethics Prize by Inamori International Center for Ethics and Excellence
Case Western Reserve University

The Inamori International Center for Ethics and Excellence at Case Western Reserve University will award Dr. Anthony Fauci, a physician, immunologist, and infectious disease expert, with the 2024 Inamori Ethics Prize.

Released: 24-Oct-2023 12:05 PM EDT
How to slow the spread of deadly ‘superbugs’
University of Technology, Sydney

Harnessing new advances in genomic surveillance technology could help detect the rise of deadly ‘superbugs’

Released: 24-Oct-2023 11:05 AM EDT
Preventing airborne infection without impeding communication with ions and electric field
Tokyo Institute of Technology

Researchers in Tokyo developed a device using ions and an electric field to capture infectious droplets and aerosols, allowing communication while preventing airborne infection

Released: 23-Oct-2023 5:05 PM EDT
How long should kids isolate after they’ve contracted COVID-19?
University of Southern California (USC)

School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.

Newswise: Registration Open for First-of-its-Kind Conference to Establish Routine Smell and Taste Testing
Released: 23-Oct-2023 12:05 PM EDT
Registration Open for First-of-its-Kind Conference to Establish Routine Smell and Taste Testing
Monell Chemical Senses Center

Registration is open for a visionary conference titled, “Towards Universal Chemosensory Testing.” The Monell Chemical Senses Center, with colleagues from Massachusetts General Hospital (MGH), The Ohio State University, and the University of Florida, organized this conference with the overarching goal to involve multiple stakeholders to develop strategies for implementing routine chemosensory testing – smell, taste, and related senses – across the lifespan as a part of healthcare in the United States.

Newswise: A Decade of Progress: Addressing Humanity’s Shared Challenges
Released: 20-Oct-2023 11:05 AM EDT
A Decade of Progress: Addressing Humanity’s Shared Challenges
Rutgers University-New Brunswick

Ten years after the creation of Rutgers Biomedical and Health Sciences, new university institutes and centers are bringing the world’s best medical ideas to New Jersey and beyond

Newswise: Broad-spectrum antiviral candidate targets dengue and SARS-CoV-2
Released: 20-Oct-2023 1:00 AM EDT
Broad-spectrum antiviral candidate targets dengue and SARS-CoV-2
Hokkaido University

A broad-spectrum antiviral drug candidate, 2-thiouridine, that targets positive-strand RNA viruses has been identified and characterized.

Newswise: Novel dynamic imaging technology captures the body’s immune response to COVID-19 infection
Released: 19-Oct-2023 2:05 PM EDT
Novel dynamic imaging technology captures the body’s immune response to COVID-19 infection
UC Davis Health

A UC Davis study shows the first-in-human imaging of the body’s CD8 T cell immune response to COVID-19 infection in recovering patients.

Released: 19-Oct-2023 1:05 PM EDT
Medicine on the base of vitamin B6 improves memory and decreases fatigue after COVID
Scientific Project Lomonosov

Scientists have showed that medicine on the base of vitamin B6 can be used for treatment of post-COVID asthenia – condition when patients complain of rapid fatigability, problems with memory and sleep. Taking of this product enabled 35% patients to improve memory, 40% patients began to sleep well, 42% of people began to get tired more slowly. Besides this taking this medicine enabled patients to experience physical activity easier. Results of the research are published in Magazine of Infectology.

Released: 19-Oct-2023 11:05 AM EDT
Canadians with peptic ulcer disease faced mental health challenges during COVID-19 pandemic
University of Toronto

The risk of depression among those with peptic ulcer disease was higher among women, those who felt lonely, those with functional limitations, those whose income did not satisfy their basic needs and those who experienced pandemic-related stressors

Released: 19-Oct-2023 10:00 AM EDT
Penn Medicine Research Sheds New Light on Immune Response During SARS-CoV-2 Breakthrough Infections
Perelman School of Medicine at the University of Pennsylvania

While COVID-19 breakthrough infections—a SARS-CoV-2 infection that occurs after receiving COVID-19 vaccines—can occur, for healthy individuals with vaccine-induced immunity, these breakthrough infections do not often cause severe disease.

Newswise: Pandemic Prevention Consortium Announces New Leadership Team
Released: 19-Oct-2023 8:15 AM EDT
Pandemic Prevention Consortium Announces New Leadership Team
Tufts University

STOP Spillover, a project funded by the U.S. Agency for International Development (USAID) and led by Tufts University, has announced that the interim leadership team that was put in place in March 2023 will take on a permanent role for the next two years of the project.

Newswise: Therapeutic nanocarriers reduce lung inflammation in mice
Released: 19-Oct-2023 3:20 AM EDT
Therapeutic nanocarriers reduce lung inflammation in mice
National Institute of Biomedical Imaging and Bioengineering

There is no cure or FDA-approved therapy for acute respiratory distress syndrome, which has a high rate of mortality. Inflammation plays a major role in developing ARDS. Researchers at Ohio State University developed therapeutic nanocarriers using mice skin cells, which reduced inflammation in their lungs.

   
Newswise: UMass Amherst research finds adult vaccination rates increase when out-of-pocket costs decrease
Released: 18-Oct-2023 6:05 PM EDT
UMass Amherst research finds adult vaccination rates increase when out-of-pocket costs decrease
University of Massachusetts Amherst

Adults are more likely to follow government vaccination recommendations when they do not have to pay out of pocket for the vaccine, according to a new study by a University of Massachusetts Amherst researcher.

12-Oct-2023 10:05 AM EDT
Study Finds Increased Risk of Guillain-Barré After COVID-19 Infection
American Academy of Neurology (AAN)

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that people who received the mRNA vaccine from Pfizer-BioNTech were less likely to develop the disorder in the next six weeks than people who did not receive the mRNA vaccine.

16-Oct-2023 11:05 AM EDT
From One Nightmare to Another. Anthony Fauci’s New Concern
Georgetown University Medical Center

“What keeps you up at night?” It’s a question Anthony Fauci, MD, heard repeatedly over the course of his nearly four decades as director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Today, as the COVID-19 pandemic wanes, Fauci describes a new nemesis – lack of “corporate memory.”

Released: 18-Oct-2023 12:00 PM EDT
Cancer Experts Available to Discuss Continued Impact of Covid-19 on Cancer Care
American College of Surgeons (ACS)

Cancer researchers attending the American College of Surgeons Clinical Congress 2023 in Boston will share recent national data on cancer trends related to the pandemic.

Released: 17-Oct-2023 3:05 PM EDT
Public health interventions prevented transmission within BU most SARS-CoV-2 cases
Boston University School of Medicine

Findings have implications for transmission protocols for other respiratory diseases

Released: 17-Oct-2023 2:05 PM EDT
Last Chance: Register in Advance for Media Credentials to Cover American College of Surgeons Clinical Congress 2023
American College of Surgeons (ACS)

Members of the media can still apply to cover the American College of Surgeons (ACS) Clinical Congress 2023.

Newswise: News Tip: Johns Hopkins Medicine Experts Available for Interviews on Winter Respiratory Illnesses and Vaccines
Released: 17-Oct-2023 10:00 AM EDT
News Tip: Johns Hopkins Medicine Experts Available for Interviews on Winter Respiratory Illnesses and Vaccines
Johns Hopkins Medicine

The United States’ respiratory virus season — which typically lasts from October to April — is making its annual return. The flu, COVID-19, respiratory syncytial virus (RSV) infection and other respiratory illnesses tend to circulate more in the fall and winter months, which can lead to a surge in hospitalizations.

Released: 17-Oct-2023 9:00 AM EDT
CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
Mount Sinai Health System

CastleVax, a clinical stage vaccine platform company, has received a Project NexGen award valued at up to $338 million from the Biomedical Advanced Research and Development Authority (BARDA), to support the development of a next-generation, booster vaccine to protect against COVID-19 for years to come.

Released: 16-Oct-2023 12:15 PM EDT
Mouse Model of COVID-19 in Pregnancy Shows Benefit of Paxlovid Treatment
Johns Hopkins Bloomberg School of Public Health

A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child.

Released: 16-Oct-2023 12:05 PM EDT
Holy immunity! Bat genes key against COVID, cancer
Cold Spring Harbor Laboratory

Bats have acquired remarkable traits throughout their evolution. They’re the only mammals that can fly, and they live much longer than other animals their size. But perhaps most impressive is their robust immune system. It protects bats from viruses that wreak havoc in humans, like COVID-19 or Ebola. It also keeps bats relatively cancer-free. How? According to Cold Spring Harbor Laboratory (CSHL) scientists, it’s all in the genes.

16-Oct-2023 9:05 AM EDT
Viral Persistence and Serotonin Reduction Can Cause Long COVID Symptoms, Penn Medicine Research Finds
Perelman School of Medicine at the University of Pennsylvania

Patients with long COVID – the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19 – can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according to new research published today in Cell.

Released: 13-Oct-2023 6:05 PM EDT
Targeting a coronavirus ion channel could yield new Covid-19 drugs
Massachusetts Institute of Technology (MIT)

Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation

Newswise: Vaccines: A few minutes now could spare you misery later
Released: 13-Oct-2023 8:05 AM EDT
Vaccines: A few minutes now could spare you misery later
Michigan Medicine - University of Michigan

A guide to vaccines that adults - especially older adults and those with underlying health issues - should get to avoid serious illness this fall and winter, and beyond.

Released: 12-Oct-2023 7:05 AM EDT
Study: Oral Health Workers Are Burned Out Too
University at Albany, State University of New York

University at Albany School of Public Health study shines light on rates of burnout among health care workers, leading causes of burnout and strategies to improve working conditions

Released: 11-Oct-2023 5:05 PM EDT
New research finds greater continuity of psychotherapy after shift to telehealth
American Psychiatric Association (APA)

The rapid transition to virtual care that occurred with the onset of the COVID-19 pandemic resulted in better continuity of psychotherapy visits compared to prior to the pandemic when almost all visits were in-person, according to new research published in Psychiatric Services, a journal of the American Psychiatric Association.

Newswise: An AI Tool That Can Help Forecast Viral Outbreaks
10-Oct-2023 1:05 PM EDT
An AI Tool That Can Help Forecast Viral Outbreaks
Harvard Medical School

EVEscape predicts future viral mutations, new variants using evolutionary, biological information

Newswise: He’s Always There for Us, Now We’re There For Him
Released: 10-Oct-2023 12:05 PM EDT
He’s Always There for Us, Now We’re There For Him
Hackensack Meridian Health

When Hackensack University Medical Center Security Officer Dwayne Humes walks into a room, his presence quietly commands attention. Dwayne served six years in the United States Air Force and 31 years and counting at the hospital.

Newswise: Could a specialized diet alleviate long COVID?
Released: 9-Oct-2023 12:00 PM EDT
Could a specialized diet alleviate long COVID?
Keck Medicine of USC

Approximately 7% of Americans have had long COVID, a range of ongoing health problems experienced after infection and recovery from COVID-19. Symptoms can include fatigue, brain fog, headaches, chest pain, heart palpitations and more.

Released: 9-Oct-2023 6:05 AM EDT
Clinical trial reveals benefits of inhaled nitric oxide for patients with respiratory failure due to COVID-19 pneumonia
Massachusetts General Hospital

Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults.



close
6.48918